Latest Industrial Property News

Goodman NZ (NZX:GNZ) posted a 126% jump in statutory profit to $248 million for FY26, underpinned by strong property revaluations and leasing gains. The group completed its corporatisation and stapling, launched a property funds management platform, and progressed a development pipeline exceeding $1 billion.

Goodman Group (ASX:GMG) has announced an estimated unfranked distribution of AUD 0.15 per stapled security for the six months ending 30 June 2026, maintaining its steady income stream for investors.

Garda Property Group's industrial portfolio valuation rose by $8.25 million for FY26, driven by Brisbane rent growth and land value increases, pushing the portfolio to $340.56 million.

Goodman NZ surged to a $248 million statutory profit in FY26, propelled by strong property revaluations and leasing gains, while advancing major development projects and transitioning to a stapled group structure.

Property for Industry Limited (NZX: PFI) announced a 10.5% upgrade to its full-year FY26 dividend guidance, now targeting approximately 9.50 cents per share, supported by stable cash flows and controlled capital expenditure.

Dexus has partnered with Boral to develop a massive 2.5 million square metre logistics precinct in Melbourne’s west, aiming to create Australasia’s largest institutionally held industrial hub.

Recce Pharmaceuticals bolsters its clinical and commercial pipeline with a $5.3 million AUD R&D tax rebate, a second U.S. Army research agreement for its RECCE 327 Gel, and a key patent granted in Brazil, while progressing Phase 3 trials in Indonesia.

Aguia Resources’ Brazilian subsidiary has achieved a key regulatory milestone with official fertiliser registration, enabling commercial sales of its PAMPAFOS phosphate product in Brazil’s large agricultural market.

Washington H. Soul Pattinson and Company Limited has completed its merger with Brickworks Limited, creating a diversified investment group with a $13.8 billion portfolio and reporting a $2.3 billion statutory profit for 1H26.

Recce Pharmaceuticals has expanded its intellectual property footprint with a newly granted patent in Brazil, protecting its innovative synthetic anti-infectives against a broad range of infections. This milestone strengthens Recce’s position in one of South America’s largest antibiotic markets.

Dexus Industria REIT has announced an on-market securities buy-back targeting 2.5% of its issued securities, aiming to enhance returns for investors. The buy-back is set to commence from 24 March 2026 following a mandatory waiting period.

Dexus has announced a 19.3 cents per security distribution for HY26, aligned with its updated payout policy, alongside robust financial results and a strategic 10% on-market buyback to address valuation gaps.